Drugs Market Research Reports & Industry Analysis

The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.

Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.

A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.

Publications found: 9,295

Sort by:

Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021 SUMMARY Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021 provides an...

April 2021 160 pages

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021 SUMMARY Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021...

April 2021 170 pages

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021

US$ 3,000.00

Transitional Endoplasmic Reticulum ATPase (Valosin Containing Protein or 15S Mg(2+) ATPase p97 Subunit or VCP or EC 3.6.4.6) - Drugs in Development, 2021 SUMMARY Transitional Endoplasmic Reticulum ATP...

April 2021 35 pages

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs in Development, 2021

US$ 3,000.00

Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs in Development, 2021 SUMMARY Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs...

April 2021 40 pages

Transplant Rejection (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Transplant Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Transplant Rejection pipeline landscap...

April 2021 80 pages

Trauma (Other Diseases) - Drugs in Development, 2021

US$ 2,000.00

Trauma (Other Diseases) - Drugs in Development, 2021 SUMMARY Trauma (Other Diseases) - Drugs in Development, 2021 provides an overview of the Trauma pipeline landscape. The report provides comprehensi...

April 2021 45 pages

Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Traumatic Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 provides an overview of th...

April 2021 30 pages

Traveler's Diarrhea (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Traveler's Diarrhea (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Traveler's Diarrhea (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Traveler's Diarrhea pipeline...

April 2021 40 pages

Treatment Resistant Depression (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Treatment Resistant Depression (Central Nervous System) - Drugs in Development, 2021 SUMMARY Treatment Resistant Depression (Central Nervous System) - Drugs in Development, 2021 provides an overview o...

April 2021 65 pages

Trifunctional Purine Biosynthetic Protein Adenosine 3 (Phosphoribosylglycinamide Formyltransferase or Phosphoribosylamine Glycine Ligase or Phosphoribosylformylglycinamidine Cyclo Ligase or GART or EC 2.1.2.2 or EC 6.3.3.1 or EC 6.3.4.13) - Drugs in Development, 2021

US$ 3,000.00

Trifunctional Purine Biosynthetic Protein Adenosine 3 (Phosphoribosylglycinamide Formyltransferase or Phosphoribosylamine Glycine Ligase or Phosphoribosylformylglycinamidine Cyclo Ligase or GART or EC...

April 2021 30 pages

Triggering Receptor Expressed On Myeloid Cells 1 (Triggering Receptor Expressed On Monocytes 1 or CD354 or TREM1) - Drugs in Development, 2021

US$ 3,000.00

Triggering Receptor Expressed On Myeloid Cells 1 (Triggering Receptor Expressed On Monocytes 1 or CD354 or TREM1) - Drugs in Development, 2021 SUMMARY Triggering Receptor Expressed On Myeloid Cells 1...

April 2021 30 pages

Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) - Drugs in Development, 2021

US$ 3,000.00

Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) - Drugs in Development, 2021 SUMMARY Triggering Receptor Expressed On Myeloid Cells 2 (Triggeri...

April 2021 30 pages

Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Tropomyosin Receptor Kinase (TRK or EC 2.7.10.1) - Drugs in Development, 2021 provides in depth analysis on Tropom...

April 2021 50 pages

Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Trypanosomiasis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Trypanosomiasis pipeline landsca...

April 2021 35 pages

Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Tuberous Sclerosis (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Tuberous Sclerosis pipeline...

April 2021 40 pages

Tubulin - Drugs in Development, 2021

US$ 3,500.00

Tubulin - Drugs in Development, 2021 SUMMARY Tubulin - Drugs in Development, 2021 provides in depth analysis on Tubulin targeted pipeline therapeutics. The report provides comprehensive information co...

April 2021 325 pages

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021

US$ 3,500.00

Tumor Necrosis Factor (Cachectin or TNF Alpha or Tumor Necrosis Factor Ligand Superfamily Member 2 or TNF a or TNF) - Drugs in Development, 2021 SUMMARY Tumor Necrosis Factor (Cachectin or TNF Alpha o...

April 2021 230 pages

Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Turner Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Turner Syndrome pipeline landscape...

April 2021 30 pages

Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1 Receptor or AGTR1) - Drugs in Development, 2021

US$ 3,000.00

Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1 Receptor or AGTR1) - Drugs in Development, 2021 SUMMARY Type 1 Angiotensin II Receptor (AT1AR or AT1BR or Angiotensin II Type 1...

April 2021 85 pages

Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,000.00

Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Drugs in Development...

April 2021 40 pages

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Deve...

April 2021 75 pages

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) - Drugs in Development, 2021

US$ 3,000.00

Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) - Drugs in Development, 2021 SUMMARY Tyrosyl DNA Phosphodiesterase 1 (TDP1 or EC 3.1.4.) - Drugs in Development, 2021 provides in depth analysis on...

April 2021 30 pages

Ulcers (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Ulcers (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Ulcers (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Ulcers pipeline landscape. The report provides compreh...

April 2021 30 pages

Undisclosed (Undisclosed) - Drugs in Development, 2021

US$ 2,000.00

Undisclosed (Undisclosed) - Drugs in Development, 2021 SUMMARY Undisclosed (Undisclosed) - Drugs in Development, 2021 provides an overview of the Undisclosed pipeline landscape. The report provides co...

April 2021 40 pages

Upper Limb Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Upper Limb Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 SUMMARY Upper Limb Muscle Spasticity (Central Nervous System) - Drugs in Development, 2021 provides an overview of th...

April 2021 35 pages

Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Urea Cycle Disorders (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Urea Cycle Disorders pip...

April 2021 35 pages

Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021 SUMMARY Uremic (Renal) Pruritus (Dermatology) - Drugs in Development, 2021 provides an overview of the Uremic (Renal) Pruritus pipeli...

April 2021 35 pages

Urethral Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Urethral Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Urethral Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Urethral Cancer pipeline landscape. The report provi...

April 2021 60 pages

Urinary Tract Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Urinary Tract Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Urinary Tract Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Urinary Tract Cancer pipeline landscape. T...

April 2021 35 pages

Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in Development, 2021 SUMMARY Urinary Tract Infections Due To Catheter Encrustation (Infectious Disease) - Drugs in De...

April 2021 30 pages

Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Urinary Tract...

April 2021 160 pages

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) (Dermatology) - Drugs in Development, 2021

US$ 2,000.00

Urticaria Pigmentosa (Mastocytosis, Mastocytoma) (Dermatology) - Drugs in Development, 2021 SUMMARY Urticaria Pigmentosa (Mastocytosis, Mastocytoma) (Dermatology) - Drugs in Development, 2021 provides...

April 2021 30 pages

Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021

US$ 3,000.00

Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021 SUMMARY Usherin (Usher Syndrome Type 2A Protein or USH2A) - Drugs in Development, 2021 provides in depth analysis on Ushe...

April 2021 35 pages

Uterine Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Uterine Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Uterine Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Uterine Cancer pipeline landscape. The report provides...

April 2021 110 pages

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021

US$ 3,000.00

Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021 SUMMARY Utrophin (Dystrophin Related Protein 1 or DRP1 or UTRN) - Drugs in Development, 2021 provides in depth anal...

April 2021 30 pages

Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Varicella Zoster (HHV-3) Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview...

April 2021 35 pages

Vascular Dementias (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Vascular Dementias (Central Nervous System) - Drugs in Development, 2021 SUMMARY Vascular Dementias (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Vascular Dementias...

April 2021 45 pages

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021

US$ 3,500.00

Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor A (Vascular Permeability Factor or VEGFA) - Drugs i...

April 2021 210 pages

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021

US$ 3,000.00

Vascular Endothelial Growth Factor C (Flt4 Ligand or Vascular Endothelial Growth Factor Related Protein or VEGFC) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor C (Flt4 Ligand...

April 2021 30 pages

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021

US$ 3,000.00

Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or FIGF) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor D (c Fos Induced Growth Factor or VEGFD or F...

April 2021 30 pages

Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) - Drugs in Development, 2021

US$ 3,000.00

Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor Receptor (VEGFR or EC 2.7.10.1) - Drugs in Development, 2021...

April 2021 75 pages

Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021

US$ 3,500.00

Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 SUMMARY Vascular Endothelial Growth Factor (VEGF) - Drugs in Development, 2021 provides in depth analysis on Vascular Endothelial...

April 2021 190 pages

Vascular Injury (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Vascular Injury (Cardiovascular) - Drugs in Development, 2021 SUMMARY Vascular Injury (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Vascular Injury pipeline landscape. The...

April 2021 30 pages

Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021

US$ 2,000.00

Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021 SUMMARY Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021 provides...

April 2021 45 pages

Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular/Hepatic Type Arginine Vasopressin Receptor or AVPR1A) - Drugs in Development, 2021

US$ 3,000.00

Vasopressin V1a Receptor (AVPR V1a or Antidiuretic Hormone Receptor 1a or Vascular/Hepatic Type Arginine Vasopressin Receptor or AVPR1A) - Drugs in Development, 2021 SUMMARY Vasopressin V1a Receptor (...

April 2021 40 pages

Venezuelan Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Venezuelan Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Venezuelan Equine Encephalitis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Ve...

April 2021 40 pages

Venous Thromboembolism (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Venous Thromboembolism (Cardiovascular) - Drugs in Development, 2021 SUMMARY Venous Thromboembolism (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Venous Thromboembolism pip...

April 2021 50 pages

Venous (Vein) Thrombosis (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Venous (Vein) Thrombosis (Cardiovascular) - Drugs in Development, 2021 SUMMARY Venous (Vein) Thrombosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Venous (Vein) Thrombos...

April 2021 35 pages

Vestibular Schwannoma (Acoustic Neuroma) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Vestibular Schwannoma (Acoustic Neuroma) (Oncology) - Drugs in Development, 2021 SUMMARY Vestibular Schwannoma (Acoustic Neuroma) (Oncology) - Drugs in Development, 2021 provides an overview of the Ve...

April 2021 35 pages

Vimentin (Epididymis Luminal Protein 113 or VIM) - Drugs in Development, 2021

US$ 3,000.00

Vimentin (Epididymis Luminal Protein 113 or VIM) - Drugs in Development, 2021 SUMMARY Vimentin (Epididymis Luminal Protein 113 or VIM) - Drugs in Development, 2021 provides in depth analysis on Viment...

April 2021 30 pages

Filters

Clear all